Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

MLA

Henry L. Gomez, et al. “Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.” Journal of the National Cancer Institute, vol. 113, no. 4, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....89fd850d5333328e165d9bf4d57be057&authtype=sso&custid=ns315887.

APA

Henry L. Gomez, George W. Sledge, Jeffrey L. Berenberg, Amir Faghih, Matthew P. Goetz, William C. Wood, John A. Olson, Maccon M. Keane, Joseph A. Sparano, Lynne I. Wagner, Virginia G. Kaklamani, Thomas James Saphner, Della F. Makower, Timothy F. Goggins, Deborah Toppmeyer, Pavan S. Reddy, Elizabeth Claire Dees, Daniel F. Hayes, Robert Gray, … Sunil Badve. (2020). Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. Journal of the National Cancer Institute, 113(4).

Chicago

Henry L. Gomez, George W. Sledge, Jeffrey L. Berenberg, Amir Faghih, Matthew P. Goetz, William C. Wood, John A. Olson, et al. 2020. “Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.” Journal of the National Cancer Institute 113 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....89fd850d5333328e165d9bf4d57be057&authtype=sso&custid=ns315887.